Sun Pharma Partners to Market Utreglutide in Major Markets, ETPharma

New Delhi: Indian pharma major, Sun Pharmaceuticals plans to market its investigational GLP-1 receptor agonist, utreglutide through local partnerships across large markets where it lacks the required field force, said Dilip Shanghvi, the co
Read more...